Journal of Interdisciplinary Histopathology



e-ISSN: 2146-8362



Journal Home | Instructions for Authors | Current Issue | Online First | Previous Issues

« Previous Article
Next Article »

Original Research Open Access


The Role of CD10 Immunohistochemistry in the Grading of Phyllodes Tumour of The Breast

Huzlinda Hussin,Jayalakshmi Pailoor, Peh Suat Cheng.

Abstract
Objective: To determine the relationship between the degree of CD10 expression in the stromal cells of phyllodes tumour and tumour grading.
Methods: A total of 61 cases of mammary phyllodes tumours over the past 11 years were searched from histopathology files, University Malaya Medical Centre. The paraffin blocks were retrieved and 4 ÎĽm thick slides were prepared and stained using an antibody against CD10 with the envision method. Fibroadenoma case was used as a control slide and breast myoepithelium as the internal control. Each stained slides was independantly and semiquantitatively analysed for the intensity and percentage of the stromal cells stained. The staining intensity was graded as negative (no staining), mild, moderate and strong if the staining was much weaker, slightly weaker and same intensity as that of the myoepithelium, respectively. The tumour was considered positive for CD10 if the staining intensity is moderate to strong in 20% or more of the stromal cells.
Results: 21 (44.7%) of 47 benign phyllodes tumour, 5 (83.3%) of 6 borderline phyllodes tumour and all 8 cases (100%) of malignant phyllodes tumour showed positive expression for CD10 immunostain.
Conclusions: There was a significant increase in CD10 expression in the stromal cells as the lesions progressed from benign to borderline and malignant phyllodes tumour.

Key words: Keywords: CD10, phyllodes tumour


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Huzlinda Hussin
Articles by Jayalakshmi Pailoor
Articles by Peh Suat Cheng
on Google
on Google Scholar
Article Statistics
 Viewed: 3264
Downloaded: 698
Cited: 0

REFERENCES
Tse GM, Tan PH. Recent advances in the pathology of fibroepithelial tumors of the breast. Current Diagnostic Pathology 2005; 11: 426-34.

http://dx.doi.org/10.1016/j.cdip.2005.08.007

Tse GM, Tsang AK, Putti TC, Scolyer RA, Lui PC, Law BK, Karim RZ, Lee CS. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumors. J Clin Pathol 2005; 58:186-9.

http://dx.doi.org/10.1136/jcp.2004.020917

[Pubmed]    [PMC Free Fulltext]   

Tsai WC, Jin JS, Yu JC, Sheu LF. CD10, Actin, and Vimentin expression on breast phyllodes tumors correlates with tumor grades of the WHO grading system. Int J Surg Pathol 2006; 14(2): 127-31.

http://dx.doi.org/10.1177/106689690601400204

[Pubmed]   

Zamecnik M, Kinkor Z, Chlumska A. CD10+ stromal cells in fibroadenomas and phyllodes tumors of the breast. Virchows Arch 2006; 448: 871-2.

http://dx.doi.org/10.1007/s00428-005-0131-z

[Pubmed]   

Magro G, Caltabiano R, Di Cataldo A, Puzzo L. CD10 is expressed by mammary myofibroblastoma and spindle cell lipoma of soft tissue: an additional evidence of their histogenetic linking. Virchows Arch 2007; 450: 727-8.

[Pubmed]   
Chua CL, Thomas A, Ng BK. Cystosarcoma phyllodes-Asian variations. Aus N Z J Surg 1988; 58: 301-5.

http://dx.doi.org/10.1111/j.1445-2197.1988.tb01060.x

[Pubmed]   

Fattaneh A, Tavassoli FA, Devilee P. WHO classification of tumors: Tumors of the breast and female genital organs. IARC, Lyon, pp 100-103, 2003.

Ortega E, Aranda FI, Chuliá MT, Niveiro M, Payá A, Seguí J. Phyllodes tumor of the breast with actin inclusions in stromal cells. Diag Cytopathol 2001; 25: 115-7.

http://dx.doi.org/10.1002/dc.2016

[Pubmed]   

Moffat CJ, Pinders SE, Dixon AR, Elston CW, Blamey RW, Ellis IO. Phyllodes tumors of the breast: a clinico-pathological review of thirty-two cases. Histopathology 1995; 27: 205-18.

http://dx.doi.org/10.1111/j.1365-2559.1995.tb00212.x

[Pubmed]   

Tan PH, Jayabaskar T Chuah KL, Lee HY, Tan Y, Hilmy M, Hung H, Selvarajan S, Bay BH. Phyllodes tumors of the breast. The role of pathologic parameters. Am J clin Pathol 2005; 123:529-40.

http://dx.doi.org/10.1309/U6DVBFM81MLJC1FN

[Pubmed]   

Grimes MM. Cystosarcoma phyllodes of the breast: histological features, flow cytometric analysis, and clinical correlation. Mod Pathol 1992; 5: 232-9.

[Pubmed]   

Mokbel K, Price RK, Mostafa A, Wells CA, Carpenter R. Phyllodes tumor of the breast: a retrospective analysis of 30 cases. Breast 1999; 8: 278-81.

http://dx.doi.org/10.1054/brst.1999.0058

[Pubmed]   

Tse GM, Putti TC, Kung FY, Scolyer RA, Law BK, Lau TS, Lee CS. Increased p53 protein expression in malignant mammary phyllodes tumors. Mod Pathol 2002; 15: 734–40.

http://dx.doi.org/10.1097/01.MP.0000018978.75312.5C

[Pubmed]   

Millar EK, Beretov J, Marr P, Sarris M, Clarke RA, Kearsley JH, Lee CS. Malignant phyllodes tumors of the breast display increased stromal p53 protein expression. Histopathology 1999; 34: 491–6.

http://dx.doi.org/10.1111/j.1365-2559.1999.00666.x

[Pubmed]   

Kocová L, Skálová A, Fakan F, Rousarová M. Phyllodes tumor of the breast: immunohistochemical study of 37 tumors using MIB1 antibody. Pathol Res Pract 1998; 194: 97–104.

http://dx.doi.org/10.1016/S0344-0338(98)80076-9

Tse GM, Lui PC, Scolyer RA, Putti TC, Kung FY, Law BK, Lau TS, Lee CS. Tumor angiogenesis and p53 protein expression in mammary phyllodes tumors. Mod Pathol 2003; 16: 1007–13.

http://dx.doi.org/10.1097/01.MP.0000089907.67419.42

[Pubmed]   

Tse GM, Ma TK, Chan KF, Law BK, Chen MH, Li KH, Chan EC, Mak MK. Increased microvessel density in malignant and borderline mammary phyllodes tumors. Histopathology 2001; 38: 567–70.

http://dx.doi.org/10.1046/j.1365-2559.2001.01150.x

[Pubmed]   

Sawyer EJ, Poulsom R, Hunt FT, Jeffery R, Elia G, Ellis IO, Ellis P, Tomlinson IP, Hanby AM. Malignant phyllodes tumors show stromal overexpression of c-myc and c-kit. J Pathol 2003; 200: 59–64.

http://dx.doi.org/10.1002/path.1318

[Pubmed]   

Tse GM, Putti TC, Lui PC, Lo AW, Scolyer RA, Law BK, Karim R, Lee CS. Increased c-kit (CD117) expression in malignant mammary phyllodes tumors. Mod Pathol 2004; 17: 827–31.

http://dx.doi.org/10.1038/modpathol.3800125

[Pubmed]   

Elston CW, Ellis IO. The breast. In systemic pathology, Volume 13, 3rd edition, Churchill Livingston, Edinburgh, pp 147-186, 2000.

Parkers SJ, Harries SA. Phyllodes tumors. Postgrad Med J 2001; 77: 428–35.

http://dx.doi.org/10.1136/pmj.77.909.428

[PMC Free Fulltext]   

Greaves MF, Hariri G, Newman RA, Sutherland DR, Ritter MA, Ritz J. Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood 1983; 61: 628-39.

[Pubmed]   

Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000; 24: 203-10.

http://dx.doi.org/10.1097/00000478-200002000-00006

[Pubmed]   

Chu P, Arber DA. Paraffin-section detection of CD10 in 505 non-hematopoeitic neoplasms. Am J Clin Pathol 2000; 113: 374-82.

http://dx.doi.org/10.1309/8VAV-J2FU-8CU9-EK18

[Pubmed]   

Ordi J, Romagosa C, Tavassoli FA, Nogales F, Palacin A, Condom E, Torné A, Cardesa A. CD10 expression in epithelial tissues and tumors of the gynaecologic tract: A useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am J Surg Pathol 2003; 27: 178-86.

http://dx.doi.org/10.1097/00000478-200302000-00005

[Pubmed]   

Gillette CE, Bobrow LG, Millis RR. S100 protein in human mammary tissue: Immunoreactivity in breast carcinoma, including Paget's disease of the nipple and value as a marker of myoepithelial cells. J Pathol 1990; 160: 19-24.

http://dx.doi.org/10.1002/path.1711600106

[Pubmed]   

Guelstein VI, Tchypysheva TA, Ermilova VD, Ljubimov AV. Myoepithelial and basement membrane antigen and malignant human breast tumors. Int. J. Cancer 1993; 53: 269-77.

http://dx.doi.org/10.1002/ijc.2910530217

[Pubmed]   

Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai K. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchows Arch 2002; 440: 589-93.

http://dx.doi.org/10.1007/s00428-002-0639-4

[Pubmed]   

Hayatt MA. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas: Molecular Genetics; Lung and Breast Carcinomas. In: Iwaya K, Mukai K (eds) CD10 expression in normal breast and breast cancer tissues, Elsevier Academic Press, pp 299-305, 2004.

Lu YJ, Birdsall S, Osin P, Gusterson B, Shipley J. Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence. Genes Chromosomes Cancer 1997; 20: 275–81.

http://dx.doi.org/10.1002/(SICI)1098-2264(199711)20:3<275::AID-GCC8>3.0.CO;2-#

Sawyer EJ, Hanby AM, Ellis P, Lakhani SR, Ellis IO, Boyle S, Tomlinson IP. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am J Clin Pathol 2000; 156: 1093–8.

http://dx.doi.org/10.1016/S0002-9440(10)64977-2


How to Cite this Article
Pubmed Style

Hussin H, Pailoor J, Cheng PS. The Role of CD10 Immunohistochemistry in the Grading of Phyllodes Tumour of The Breast. J Interdiscipl Histopathol. 2013; 1(4): 195-203. doi:10.5455/jihp.20130307011432



Web Style

Hussin H, Pailoor J, Cheng PS. The Role of CD10 Immunohistochemistry in the Grading of Phyllodes Tumour of The Breast. www.scopemed.org/?mno=33590 [Access: June 28, 2017]. doi:10.5455/jihp.20130307011432



AMA (American Medical Association) Style

Hussin H, Pailoor J, Cheng PS. The Role of CD10 Immunohistochemistry in the Grading of Phyllodes Tumour of The Breast. J Interdiscipl Histopathol. 2013; 1(4): 195-203. doi:10.5455/jihp.20130307011432



Vancouver/ICMJE Style

Hussin H, Pailoor J, Cheng PS. The Role of CD10 Immunohistochemistry in the Grading of Phyllodes Tumour of The Breast. J Interdiscipl Histopathol. (2013), [cited June 28, 2017]; 1(4): 195-203. doi:10.5455/jihp.20130307011432



Harvard Style

Hussin, H., Pailoor, J. & Cheng, P. S. (2013) The Role of CD10 Immunohistochemistry in the Grading of Phyllodes Tumour of The Breast. J Interdiscipl Histopathol, 1 (4), 195-203. doi:10.5455/jihp.20130307011432



Turabian Style

Hussin, Huzlinda, Jayalakshmi Pailoor, and Peh Suat Cheng. 2013. The Role of CD10 Immunohistochemistry in the Grading of Phyllodes Tumour of The Breast. Journal of Interdisciplinary Histopathology, 1 (4), 195-203. doi:10.5455/jihp.20130307011432



Chicago Style

Hussin, Huzlinda, Jayalakshmi Pailoor, and Peh Suat Cheng. "The Role of CD10 Immunohistochemistry in the Grading of Phyllodes Tumour of The Breast." Journal of Interdisciplinary Histopathology 1 (2013), 195-203. doi:10.5455/jihp.20130307011432



MLA (The Modern Language Association) Style

Hussin, Huzlinda, Jayalakshmi Pailoor, and Peh Suat Cheng. "The Role of CD10 Immunohistochemistry in the Grading of Phyllodes Tumour of The Breast." Journal of Interdisciplinary Histopathology 1.4 (2013), 195-203. Print. doi:10.5455/jihp.20130307011432



APA (American Psychological Association) Style

Hussin, H., Pailoor, J. & Cheng, P. S. (2013) The Role of CD10 Immunohistochemistry in the Grading of Phyllodes Tumour of The Breast. Journal of Interdisciplinary Histopathology, 1 (4), 195-203. doi:10.5455/jihp.20130307011432